Pelitinib (EKB‐569) targets the up‐regulation of ABCB1 and ABCG2 induced by hyperthermia to eradicate lung cancer
Publisher: John Wiley & Sons Inc
E-ISSN: 1476-5381|172|16|4089-4106
ISSN: 0007-1188
Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.16, 2015-08, pp. : 4089-4106
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract